Gunilla Osswald | BiotechTV

top of page

Pareto Securities' Healthcare Conference: BioArctic's CEO Gunilla Osswald highlights the company's brain transporter technology, the latest on Leqembi, and a Parkinson's program

She describes the transferrin receptor based brain transporter technology, which the company recently signed another new partner...

Company News

Sep 16

The CEO of BioArctic talks Leqembi and what's next in Alzheimer's, Parkinson's, ALS, and more

Gunilla Osswald talks about the global approvals Leqembi has received, she makes the case for a European approval, and talks about what...

Company News

Sep 21, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

Pareto Securities' Healthcare Conference: BioArctic's CEO Gunilla Osswald highlights the company's brain transporter technology, the latest on Leqembi, and a Parkinson's program

The CEO of BioArctic talks Leqembi and what's next in Alzheimer's, Parkinson's, ALS, and more

Follow BiotechTV

Sponsors

Sponsor Spotlight